Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Impact of chronic obstructive pulmonary disease on survival after chimeric antigen receptor T-cell therapy in large B-cell lymphoma
Mehmet S. Uyanik; Athanasios Tsalatsanis; Ibrahim Muhsen; Aditi Saha; Mahmoud Aljurf; Hong Qin; Julio C. Chavez; Ambuj Kumar; Mohamed A. Kharfan-DabajaShow moreShow less
Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA; Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC, USA; Research Methodology and Biostatistics Core, Office of Research, Morsani College of Medicine, University of South Florida, Tampa, FL, USA; Division of Hematology-Oncology and O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA; King Faisal Specialist Hospital & Research Centre, Adult Stem Cell Transplantation and Cellular Therapy Program, Riyadh, Saudi ArabiaShow moreShow less
Post-transplant lineage transformation to blastic plasmacytoid dendritic cell neoplasm in advanced systemic mastocytosis with associated CMML: a case report
Omar Khaled; Alexander Woodman; Camron Farjami; Zachary Goldstein; Eric Leon Tam; Karrune Woan; Preet Chaudhary; Amir Ali; Imran S Siddiqi; George YaghmourShow moreShow less
Keck School of Medicine, University of Southern California, Los Angeles, California, USA; Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, Norris Comprehensive Cancer Center, Los Angeles, California, USA; Department of Dermatopathology, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA; Department of Pharmacy, University of Southern California, Norris Comprehensive Cancer Center, California, Los Angeles, USA; Division of Pathology, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California, USAShow moreShow less
A shared-care model for autologous transplantation: Feasibility and optimization of tertiary center resources
Ana Jiménez-Ubieto; Adolfo Jesús Sáez Marín; Paula Lázaro; José María Sánchez Pina; Rodrigo Iñiguez García; Magdalena Corona; Rafael Alonso; Laura Montejano; Pilar Martínez-Sánchez; Daniel Gil-Alos; Nieves López; Guillermo Ramos; Pilar Bravo; María Stefania Infante; José-Ángel Hernández-Rivas; Juan Churruca; Renata García-Gigorro; Iryna Luts; Fernando Solano; Jacobo Galán Vega; Joaquín Martínez-López; Juan José Lahuerta; M. CalbachoShow moreShow less
Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain; Imas12 Research Institute, Hospital Universitario 12 de Octubre, Madrid, Spain; Department of Hematology, Hospital Universitario La Paz, Madrid, Spain; Department of Hematology, Hospital Universitario de Fuenlabrada, Madrid, Spain; Department of Hematology, Hospital Universitario Infanta Leonor, Madrid, Spain; Department of Intensive Care, Hospital Universitario Infanta Leonor, Madrid, Spain; Department of Hematology, Hospital General Universitario Nuestra Señora del Prado, Talavera de la Reina, SpainShow moreShow less
Synthesis, Evaluation, and Effect of Anti-CD38 Single-chain Immunotoxin on HL-60 acute myeloid Leukemia cell Line
Atefeh Habibi Asl; Reza Valadan; Saeid Taghiloo; Nazanin Joudaki; Hossein Asgarian-Omran; Ehsan Zaboli; Mahdieh Darvishkhezri; Abolghasem AjamiShow moreShow less
Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran; Immunogenetics Research Center, Mazandaran University of Medical Sciences, Sari, Iran; Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Gastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran; Department of Infectious Diseases, Antimicrobial Resistance Research Center, Mazandaran University of Medical Sciences, Sari, IranShow moreShow less
Academic manufacturing of anti-CD19 CAR-T cells from a leukapheresis with a high proportion of acute myeloid leukaemia blasts
Alexis Cuffel; Aurélie Bisson; Philippe Ruminy; Vinciane Rainville; Justine Dehayes; Arnaud Fleury; Clara Blondel; Maud Maho-Vaillant; Catherine Boutet; Véronique Saada; Célia Lobrano; Camille Giverne; Jérémie Martinet; Olivier Boyer; Jean-Baptiste LatoucheShow moreShow less
CHU de Rouen, Laboratoire d’Immunologie et de Biothérapies, Université de Rouen Normandie, Inserm, UMR 1234, F-76000 Rouen, France; Université de Rouen Normandie, Inserm, UMR 1245, Centre Henri Becquerel, Rouen, France; CHU de Rouen, Laboratoire d’Hématologie, F-76000 Rouen, France; Institut Gustave Roussy, Département de Biologie et Pathologie médicales, Université Paris-Saclay, F-94805, Villejuif, France; CHU Lille, Univ. Lille, Inserm, U1286 - INFINITE - Institute for Translational Research in Inflammation, 59000 Lille, FranceShow moreShow less
Impact of bone marrow fibrosis on disease characteristics and outcomes in newly diagnosed multiple myeloma patients
Ali Ahadzade; Tugrul Elverdi; Selin Kucukyurt; Abdulkadir Ercaliskan; Tuba Ozkan; Ahu Senem Demiröz; Deniz Ozmen; Umut Yılmaz; Ahmet Emre Eskazan; Muhlis Cem Ar; Yıldız Aydın; Ayse SalihogluShow moreShow less
Division of Hematology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkey; Department of Pathology, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, TurkeyShow moreShow less
FAQ
How long does Current Research in Translational Medicine take to review a manuscript?
As of 2026-11-14, CrushSCI has 15 complete review records for Current Research in Translational Medicine. The fastest paper went from submission to acceptance in 18 days (Academic manufacturing of anti-CD19 CAR-T cells from a leukapheresis with a high proportion of acute myeloid leukaemia blasts, received 2026-08-27, accepted 2026-09-14); the slowest took 344 days. The average is 159.7 days and the median is 161 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
